GEORGE G. PITARRA, JR.

**** ******** ***** ********* ** 94550

Mobile: 949-***-**** Email: ad0inb@r.postjobfree.com SENIOR FINANCIAL MANAGEMENT EXECUTIVE

H E L P I N G B U I L D A N D L E A D D I V E R S I F I E D C O M P A N I E S — P O S I T I O N I N G F O R RAP I D, S U S T A I N E D G R O W T H I N P R O F I T A B L E S A L E S A N D E N T E R P R I S E V A L U E

Record of focused, growth-oriented, strategic leadership and financially oriented management that boosts profitability, speeds time to market, reverses poor financial performance, and drives progress for multinational corporations and emerging growth companies. Strong executive-leadership competencies in all areas of the organization; talent for identifying strategy, communicating vision, developing tactical plans, and motivating and empowering individuals and teams to achieve ambitious goals. As Executive VP and CFO and right hand to CEO, key player in the growth and subsequent phenomenally successful sale of two life science/medical device companies.

Following sale of The Polymer Technology Group (biomaterials), established Emergence Venture Partners with former CEO, raising $10 million from former investors.

o As co-founder, EVP and CFO, raised $18 million for ExThera Medical (single-use blood filters for capturing bacteria, viruses, parasites, toxins and other sepsis mediators), including participation from global strategic investor Fresenius Medical Care.

Previously, as EVP and CFO of The Polymer Technology Group, Inc. (currently DSM Biomedical – biomaterials/medical devices), played leading role in business development efforts that added $200 million in revenues within three years.

o Key member of negotiating team that doubled the offer from multi-billion-dollar revenue European strategic buyer – achieving a shareholder return of 555 times original capital investment.

Earlier, CFO then promoted to CEO of Humanetics Innovative Solutions which, at the time of appointment, was a struggling R&D medical device/safety equipment manufacturer. Completed comprehensive turnaround in one year. o Achieved consistent annual growth over 7 years – driving a ten-fold increase in sales with an average ROS of 32%

o Led negotiations for the sale of the company to a publicly traded UK corporation, acquired competitor. o Appointed CEO of the combined enterprises and managed the consolidation and integration of two businesses on one greenfield site in Michigan. Created the dominant global factor in automobile safety evaluation testing systems.

P R O F I C I E N C I ES

Market Access Strategy Development Business Development Financial Modelling P&L Management Team Development and Training Capital Acquisition Mergers & Acquisitions Start-Ups E D U C A T I O N & AFF I L I A T I ONS

MBA - Finance and Marketing - University of Southern California, Los Angeles, CA - Beta Gamma Sigma Honorary MS – Engineering – Tufts University, Medford, MA

BS – Engineering - Tufts University, Medford, MA – Tau Beta Pi Honorary George G Pitarra, Jr. Page 2 of 3 ad0inb@r.postjobfree.com E X P E R I E N C E & A C H I E V E MENTS

Regency Biosciences Consulting LLC, Livermore, CA 2019 to Present Life science consulting firm providing services to medtech, biotech and pharma companies. MANAGING DIRECTOR

Founded firm to assist companies seeking to address urgent, unmet needs in medical care for patients with intractable illness.

Currently assisting CEO of D&P BioInnovations to raise $12 million. BioInnovations has a patent pending technology to use resorbable polymers as a framework for using the patient’s stem cells to rebuild an esophagus removed due to cancer. Rather than surgically attach the top of the stomach to the throat, the esophagus is rebuilt, with the resorbable polymer disappearing as the stem cells create their own structure. https://dpbioinnovations.com/

Leading senior life science professionals to build compelling business models with strategic and tactical plans for rapid market uptake by addressing significant unmet needs in the health care system.

Active member of OCTANE, Orange County, California. https://octaneoc.org/ EMERGENCE VENTURE PARTNERS, LLC, Berkeley, CA 2008 to 2019 Life science business accelerator and incubator specializing in medical devices. Focus on biomaterials enabling technology for enhanced product performance, safety and competitive market advantage. PRESIDENT & MANAGING DIRECTOR

Co-founded organization to accelerate the development and application of biomaterial technologies in life science start-up companies. Secured initial $10 million capital for seed funding. Recruited Board of Advisors. Managed two funds for investment in startup and early-stage medical device companies with biomaterials intense requirements. Identified and managed negotiations for investments in medical device startup companies, including:

ExThera Medical: Launched joint venture with technology transfer company from the Karolinska Institute. Targeted reduction of pathogenic bioburden in bloodstream infections and calming of the dysregulated inflammatory response as result of pathogen invasion and other insults.

o With CEO, led daily operations as EVP and CFO, developed strategic business and market launch plan, completed more than $15 million in funding and recruited specialty medical device distributors to launch product in Europe and the U.S. Led effort to register trademark “Speed is Life.”

THE POLYMER TECHNOLOGY GROUP, INC. (CURRENTLY DSM BIOMEDICAL), Berkeley, CA 2005 to 2008 Privately held biomaterials and medical device company serving the business-to-business medical device industry. EXECUTIVE VICE PRESIDENT & CHIEF FINANCIAL OFFICER Created innovative strategies for rapidly improving new business development and market penetration initiatives, based on restructuring of management reporting systems. M&A exit transaction completed in 2008. Led financial reporting, accounting, treasury, tax, and information technology operations. Served as “shadow” CFO during subsequent 3 year earn-out period. Reported to Founder and CEO.

Generated $200 million in additional revenue without margin erosion by establishing pricing structure that enabled Fortune 25 client to approve business case for launch of a critical contact lens product line extension.

Designed and installed a comprehensive full absorption cost accounting system with product line segment reporting within 3 months. Revised and updated financial reporting package for Board of Directors and senior management team. Achieved

“Exceptional Contributor” performance rating 3 consecutive years. George G Pitarra, Jr. Page 3 of 3 ad0inb@r.postjobfree.com

Key player on negotiating team for company sale post unsolicited acquisition offer from a $12B European corporation. Achieved agreement for sale under earn-out structure at 9 figure consideration – more than doubling original offer - providing a 555X gain on original invested capital. Post-closing, revenue doubled in two years, with operating profits expanding four-fold due to success of key client product line extension. MAGELLAN CONSULTING GROUP, Irvine, CA 1992–2005

CHIEF EXECUTIVE OFFICER

Founded boutique multidisciplinary consulting firm. Built thriving consulting practice addressing emerging growth businesses. Example assignments included:

Medical Device Manufacturer (Triflo Medical) – Appointed Interim CEO for three years to manage and redirect company from ineffective research and development, including correcting an errant preclinical test plan. Built strategic plan to obtain CE Mark and FDA clearance.

Start-Up Computer Company - Successful profit improvement achieved through improved production methods and fund raising of $50 million.

Automotive Parts Manufacturer (Python Injection) – Appointed part time CFO, developed strategic business plan and raised

$10 million in mezzanine funds to support 5X growth. In addition, supported CEO in improving distribution through established auto parts suppliers, including Auto Zone.

Hospital Financing – Assisted a private equity group in planning for the construction of an American style hospital in Cancun, Mexico, to attract Americans to retire in its new housing development in Quintana Roo province. HUMANETICS INNOVATIVE SOLUTIONS, Carson, CA and Plymouth, MI 1985–1992 Medical products and human survival and safety assessment equipment manufacturer. https://humanetics.humaneticsgroup.com/

CHIEF EXECUTIVE OFFICER, 1988–1992

CHIEF OPERATING OFFICER / CHIEF FINANCIAL OFFICER / DIRECTOR, 1985–1988 Transformed company from a financially unsuccessful R&D firm with a 13-year history of marginal market and financial performance into a focused, professionally staffed, fully integrated systems supplier with dynamic, customer-driven engineering, manufacturing, quality, and marketing organizations. M&A transaction completed within three years of tenure.

Set strategic direction and established significant sustained profitability.

At request of Board of Directors managed negotiations for sale of the company to a British corporation, First Technology plc.

Appointed CEO by new corporate owner. Defined strategic, financial, and operational plans to execute an aggressive international expansion, building a globally dominant position resulting in capture of 85% market share.

After acquiring competitive company, relocated both entities from East and West coasts to Michigan, merged operations and relaunched company under new name.

Achieved uninterrupted revenue and earnings growth for 7 consecutive years; increased sales volume 10X and delivered consistent return on sales of 32%.

PRIOR TENURES

MAX FACTOR & COMPANY, Hollywood, CA

MANAGER, CORPORATE PLANNING & GLOBAL CAPITAL EXPENDITURES BECKMAN INSTRUMENTS-CLINICAL INSTRUMENTS DIVISION, Fullerton, CA SENIOR FINANCIAL ANALYST

Contact this candidate